In our cohort, all patients with manifest supranuclear oculomotor palsy had brain tau deposits with variable characteristics (PSP, ARTAG, and GGT), while patients without tau deposits on autopsy showed no oculomotor impairment. The gene discussed is MAPT; the disease is supranuclear oculomotor palsy.